(VIANEWS) – Rocky Brands (RCKY), CarGurus (CARG), Fresenius Medical Care AG (FMS) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Rocky Brands (RCKY)

97% sales growth and 14.58% return on equity

Rocky Brands, Inc. designs, manufactures, and markets footwear and apparel under the Rocky, Georgia Boot, Durango, Lehigh, and licensed Michelin brand names in the United States, Canada, and internationally.

Rocky Brands’s sales growth this year is expected to be 96% and 9.8% for next year.

Year-on-year quarterly revenue growth grew by 134.2%, now sitting on 384.67M for the twelve trailing months.

Volume

Today’s last reported volume for Rocky Brands is 20792 which is 59.3% below its average volume of 51095.

Rocky Brands’s sales growth for the next quarter is 97%. The company’s growth estimates for the current quarter and the next is 31.7% and 50.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.58%.

Volatility

Rocky Brands’s last day, last week, and last month’s current volatility was 1.91%, 1.17%, and 1.69%, respectively.

Rocky Brands’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.86% (day), 3.37% (last week), and 3.53% (last month), respectively.

Rocky Brands’s Stock Yearly Top and Bottom Value

Rocky Brands’s stock is valued at $55.34 at 06:22 EST, way below its 52-week high of $69.00 and way above its 52-week low of $27.00.

Rocky Brands’s Moving Average

Rocky Brands’s value is higher than its 50-day moving average of $50.37 and higher than its 200-day moving average of $52.42.

2. CarGurus (CARG)

46.7% sales growth and 23.27% return on equity

CarGurus, Inc. operates an online automotive marketplace connecting buyers and sellers of new and used cars in the United States and internationally.

CarGurus’s sales growth this year is expected to be 50.5% and 18.3% for next year.

Year-on-year quarterly revenue growth grew by 129.8%, now sitting on 688.14M for the twelve trailing months.

Volume

Today’s last reported volume for CarGurus is 1029370 which is 1.03% below its average volume of 1040090.

CarGurus’s sales growth for the next quarter is 46.7%. The company’s growth estimates for the ongoing quarter and the next is a negative 13.5% and negative -3.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.27%.

Volatility

CarGurus’s last day, last week, and last month’s current volatility was 0.12%, 1.13%, and 1.82%, respectively.

CarGurus’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.66% (day), 3.29% (last week), and 3.56% (last month), respectively.

CarGurus’s Stock Yearly Top and Bottom Value

CarGurus’s stock is valued at $33.58 at 06:22 EST, under its 52-week high of $36.54 and way above its 52-week low of $20.81.

CarGurus’s Moving Average

CarGurus’s value is above its 50-day moving average of $32.93 and way higher than its 200-day moving average of $28.73.

3. Fresenius Medical Care AG (FMS)

27.6% sales growth and 9.51% return on equity

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally.

Fresenius Medical Care AG’s sales growth this year is expected to be 19.2% and 4.6% for next year.

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 222287 which is 39.25% below its average volume of 365909.

Fresenius Medical Care AG’s sales growth for the next quarter is 27.6%. The company’s growth estimates for the current quarter and the next is a negative 26% and negative -24.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.51%.

Volatility

Fresenius Medical Care AG’s last day, last week, and last month’s current volatility was 0.58%, 1.62%, and 1.31%, respectively.

Fresenius Medical Care AG’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.42% (day), 1.00% (last week), and 0.96% (last month), respectively.

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $34.72 at 06:22 EST, way below its 52-week high of $44.13 and higher than its 52-week low of $33.84.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s worth is below its 50-day moving average of $35.60 and way below its 200-day moving average of $39.03.

4. Materialise NV (MTLS)

16.4% sales growth and 3.51% return on equity

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific.

Materialise NV’s sales growth this year is expected to be 14.4% and 12.1% for next year.

Year-on-year quarterly revenue growth grew by 28%, now sitting on 193.76M for the twelve trailing months.

Volume

Today’s last reported volume for Materialise NV is 246976 which is 8.07% below its average volume of 268681.

Materialise NV’s sales growth for the next quarter is 16.4%. The company’s growth estimates for the present quarter and the next is 400% and 700%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.51%.

Volatility

Materialise NV’s last day, last week, and last month’s current volatility was 4.31%, 5.60%, and 3.01%, respectively.

Materialise NV’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.48% (day), 6.16% (last week), and 4.69% (last month), respectively.

Materialise NV’s Stock Yearly Top and Bottom Value

Materialise NV’s stock is valued at $24.13 at 06:22 EST, way under its 52-week high of $87.40 and way higher than its 52-week low of $18.50.

Materialise NV’s Moving Average

Materialise NV’s value is way higher than its 50-day moving average of $21.40 and above its 200-day moving average of $23.73.

5. Autodesk (ADSK)

15.8% sales growth and 188.47% return on equity

Autodesk, Inc. operates as a software design and services company worldwide.

Autodesk’s sales growth this year is expected to be 15.3% and 18.9% for next year.

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 4.04B for the twelve trailing months.

Volume

Today’s last reported volume for Autodesk is 672702 which is 49.77% below its average volume of 1339260.

Autodesk’s sales growth is a negative 0% for the present quarter and 15.8% for the next. The company’s growth estimates for the current quarter and the next is 21.2% and 23.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 188.47%.

Volatility

Autodesk’s last day, last week, and last month’s current volatility was 0.83%, 1.10%, and 1.53%, respectively.

Autodesk’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.09% (day), 1.98% (last week), and 1.93% (last month), respectively.

Autodesk’s Stock Yearly Top and Bottom Value

Autodesk’s stock is valued at $315.01 at 06:22 EST, under its 52-week high of $344.39 and way higher than its 52-week low of $241.46.

Autodesk’s Moving Average

Autodesk’s worth is above its 50-day moving average of $290.85 and higher than its 200-day moving average of $295.67.

LEAVE A REPLY

Please enter your comment!
Please enter your name here